Moreover, the deconvolution result showed high CAFs proportion, just like high Cafs, robustly correlated with poor survival in TCGA cohort, suggesting a prospective adoption to CAFs biomarkers for HNSCC treatment. The gene discussed is TBX1; the disease is head and neck squamous cell carcinoma.